Goto

Collaborating Authors

 predict breast cancer


Learn To Predict Breast Cancer Using Machine Learning

#artificialintelligence

Learn to build three Machine Learning models (Logistic regression, Decision Tree, Random Forest) from scratch - Free Course. Here you will learn to build three models that are Logistic regression model, the Decision Tree model, and Random Forest Classifier model using Scikit-learn to classify breast cancer as either Malignant or Benign. We will use the Breast Cancer Wisconsin (Diagnostic) Data Set from Kaggle. You should be familiar with the Python Programming language and you should have a theoretical understanding of the three algorithms that is Logistic regression model, Decision Tree model, and Random Forest Classifier model.


Using AI to predict breast cancer and personalize care

#artificialintelligence

"Rather than taking a one-size-fits-all approach, we can personalize screening around a woman's risk of developing cancer," says Barzilay, senior author of a new paper about the project out recently in Radiology. "For example, a doctor might recommend that one group of women get a mammogram every other year, while another higher-risk group might get supplemental MRI screening." Barzilay is the Delta Electronics Professor at CSAIL and the Department of Electrical Engineering and Computer Science at MIT and a member of the Koch Institute for Integrative Cancer Research at MIT.


MIT AI tool can predict breast cancer up to 5 years early, works equally well for white and black patients โ€“ TechCrunch

#artificialintelligence

MIT's Computer Science and Artificial Intelligence Lab has developed a new deep learning-based AI prediction model that can anticipate the development of breast cancer up to five years in advance. Researchers working on the product also recognized that other similar projects have often had inherent bias because they were based overwhelmingly on white patient populations, and specifically designed their own model so that it is informed by "more equitable" data that ensures it's "equally accurate for white and black women." That's key, MIT notes in a blog post, because black women are more than 42 percent more likely than white women to die from breast cancer, and one contributing factor could be that they aren't as well-served by current early detection techniques. MIT says that its work in developing this technique was aimed specifically at making the assessment of health risks of this nature more accurate for minorities, who are often not well represented in development of deep learning models. The issue of algorithmic bias is a focus of a lot of industry research and even newer products forthcoming from technology companies working on deploying AI in the field.


MIT AI tool can predict breast cancer up to 5 years early, works equally well for white and black patients โ€“ TechCrunch

#artificialintelligence

MIT's Computer Science and Artificial Intelligence Lab has developed a new deep learning-based AI prediction model that can anticipate the development of breast cancer up to five years in advance. Researchers working on the product also recognized that other similar projects have often had inherent bias because they were based overwhelmingly on white patient populations, and specifically designed their own model so that it is informed by "more equitable" data that ensures it's "equally accurate for white and black women." That's key, MIT notes in a blog post, because black women are more than 42 percent more likely than white women to die from breast cancer, and one contributing factor could be that they aren't as well-served by current early detection techniques. MIT says that its work in developing this technique was aimed specifically at making the assessment of health risks of this nature more accurate for minorities, who are often not well represented in development of deep learning models. The issue of algorithmic bias is a focus of a lot of industry research and even newer products forthcoming from technology companies working on deploying AI in the field.


Using AI to predict breast cancer and personalize care

#artificialintelligence

Despite significant advancements in genetics and modern imaging technology, for the vast majority of breast cancer patients, the diagnosis catches them by surprise. For some, it comes too late. Later diagnosis means aggressive treatments, anxiety and uncertain outcomes. Therefore, identifying patients at risk before the disease develops has been a central pillar to breast cancer research and effective early detection programs. A team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and Massachusetts General Hospital (MGH) has created a new deep learning model that can predict from a mammogram if a patient is likely to develop breast cancer in the future.


Using AI to predict breast cancer and personalize care

#artificialintelligence

Despite major advances in genetics and modern imaging, the diagnosis catches most breast cancer patients by surprise. For some, it comes too late. Later diagnosis means aggressive treatments, uncertain outcomes, and more medical expenses. As a result, identifying patients has been a central pillar of breast cancer research and effective early detection. With that in mind, a team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and Massachusetts General Hospital (MGH) has created a new deep-learning model that can predict from a mammogram if a patient is likely to develop breast cancer as much as five years in the future.


Researchers harness machine learning to predict breast cancer

#artificialintelligence

A Dartmouth research team is harnessing machine learning technology to predict malignant breast cancer lesions. Saeed Hassanpour, assistant professor of biomedical data science and epidemology at the Geisel School of Medicine, and his team are focused on developing this technology to predict the possibility that a breast lesion found during medical examinations is or will become cancerous. Hassanpour said that breast cancer screenings are widely used, but can induce a false positive, which put women in danger of overdiagnosis and overtreatment. He explained that typically, if a lesion is found after a mammography, doctors perform a core needle biopsy on the patient. If a marker for high risk breast cancer incidences, known as atypical ductal hyperplasia, is found, surgery is performed to determine whether the lesion is malignant or benign, according to Hassanpour.